Recent Finacing
Recent Raise
Aronora is a clinical-stage biotech in Portland developing E-WE thrombin (AB002) thrombolytic and Gruticibart (AB023), an anti–factor XI antibody, both completed phase 2a trials and advancing toward late-stage development.
